BioNTech SE (BNTX) Net Shares Issued and Repurchased (2022 - 2023)

BioNTech SE (BNTX) reported Net Shares Issued and Repurchased of -$860751.9 for Q4 2023, up 99.74% sequentially from -$328.4 million in Q3 2023.

BioNTech SE (BNTX) Net Shares Issued and Repurchased (2022 - 2023) Analysis & Trends

BioNTech SE (BNTX) has 2 years of Net Shares Issued and Repurchased data on file, last reported at -$860751.9 in Q4 2023.

For the quarter ending Q4 2023, Net Shares Issued and Repurchased changed N/A year-over-year to -$860751.9; the trailing twelve-month figure through Dec 2023 stood at -$799.7 million (changed N/A YoY), and the FY2023 full-year result was -$794.6 million, changed N/A from the prior year.
Net Shares Issued and Repurchased advanced to -$860751.9 in Q4 2023, from -$328.4 million in the prior quarter.
In the past five years, Net Shares Issued and Repurchased ranged from a high of -$860751.9 in Q4 2023 to a low of -$649.1 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Shares Issued (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	BioNTech SE	22.13 Bn	22.13 Bn	668.28 Mn	-

Download Data